Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.71
DHRM's Cash to Debt is ranked lower than
69% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. DHRM: 0.71 )
Ranked among companies with meaningful Cash to Debt only.
DHRM' s 10-Year Cash to Debt Range
Min: 0.19  Med: 1.05 Max: 3.91
Current: 0.71
0.19
3.91
Equity to Asset 0.88
DHRM's Equity to Asset is ranked higher than
90% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. DHRM: 0.88 )
Ranked among companies with meaningful Equity to Asset only.
DHRM' s 10-Year Equity to Asset Range
Min: 0.51  Med: 0.82 Max: 0.88
Current: 0.88
0.51
0.88
F-Score: 4
Z-Score: 2.50
M-Score: -1.82
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -17.62
DHRM's Operating margin (%) is ranked lower than
66% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. DHRM: -17.62 )
Ranked among companies with meaningful Operating margin (%) only.
DHRM' s 10-Year Operating margin (%) Range
Min: -17.62  Med: 20.53 Max: 27.09
Current: -17.62
-17.62
27.09
Net-margin (%) 8.33
DHRM's Net-margin (%) is ranked higher than
72% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. DHRM: 8.33 )
Ranked among companies with meaningful Net-margin (%) only.
DHRM' s 10-Year Net-margin (%) Range
Min: 8.33  Med: 14.34 Max: 23.17
Current: 8.33
8.33
23.17
ROE (%) 2.55
DHRM's ROE (%) is ranked lower than
52% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. DHRM: 2.55 )
Ranked among companies with meaningful ROE (%) only.
DHRM' s 10-Year ROE (%) Range
Min: 2.59  Med: 11.04 Max: 33.66
Current: 2.55
2.59
33.66
ROA (%) 2.18
DHRM's ROA (%) is ranked higher than
55% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. DHRM: 2.18 )
Ranked among companies with meaningful ROA (%) only.
DHRM' s 10-Year ROA (%) Range
Min: 2.24  Med: 8.70 Max: 17.35
Current: 2.18
2.24
17.35
ROC (Joel Greenblatt) (%) 2.23
DHRM's ROC (Joel Greenblatt) (%) is ranked lower than
51% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.52 vs. DHRM: 2.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DHRM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 2.29  Med: 15.54 Max: 61.75
Current: 2.23
2.29
61.75
Revenue Growth (3Y)(%) -23.60
DHRM's Revenue Growth (3Y)(%) is ranked lower than
89% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. DHRM: -23.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
DHRM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -23.6  Med: -2.25 Max: 15.1
Current: -23.6
-23.6
15.1
EBITDA Growth (3Y)(%) -36.10
DHRM's EBITDA Growth (3Y)(%) is ranked lower than
91% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. DHRM: -36.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
DHRM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -36.1  Med: -12.65 Max: 18.3
Current: -36.1
-36.1
18.3
EPS Growth (3Y)(%) -36.10
DHRM's EPS Growth (3Y)(%) is ranked lower than
87% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. DHRM: -36.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
DHRM' s 10-Year EPS Growth (3Y)(%) Range
Min: -36.1  Med: -17.20 Max: 30.6
Current: -36.1
-36.1
30.6
» DHRM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DHRM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 9.08
DHRM's P/E(ttm) is ranked higher than
94% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. DHRM: 9.08 )
Ranked among companies with meaningful P/E(ttm) only.
DHRM' s 10-Year P/E(ttm) Range
Min: 1.52  Med: 3.98 Max: 24.05
Current: 9.08
1.52
24.05
Forward P/E 5.79
DHRM's Forward P/E is ranked higher than
98% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.31 vs. DHRM: 5.79 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 8.20
DHRM's PE(NRI) is ranked higher than
94% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 28.40 vs. DHRM: 8.20 )
Ranked among companies with meaningful PE(NRI) only.
DHRM' s 10-Year PE(NRI) Range
Min: 1.52  Med: 3.98 Max: 24.05
Current: 8.2
1.52
24.05
P/B 0.23
DHRM's P/B is ranked higher than
99% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 3.01 vs. DHRM: 0.23 )
Ranked among companies with meaningful P/B only.
DHRM' s 10-Year P/B Range
Min: 0.21  Med: 0.40 Max: 1.35
Current: 0.23
0.21
1.35
P/S 0.76
DHRM's P/S is ranked higher than
87% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. DHRM: 0.76 )
Ranked among companies with meaningful P/S only.
DHRM' s 10-Year P/S Range
Min: 0.29  Med: 0.66 Max: 2.86
Current: 0.76
0.29
2.86
POCF 2.22
DHRM's POCF is ranked higher than
98% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 22.08 vs. DHRM: 2.22 )
Ranked among companies with meaningful POCF only.
DHRM' s 10-Year POCF Range
Min: 2  Med: 5.05 Max: 10.41
Current: 2.22
2
10.41
EV-to-EBIT 14.82
DHRM's EV-to-EBIT is ranked higher than
71% of the 159 Companies
in the Global Medical Devices industry.

( Industry Median: 21.34 vs. DHRM: 14.82 )
Ranked among companies with meaningful EV-to-EBIT only.
DHRM' s 10-Year EV-to-EBIT Range
Min: -10.6  Med: 2.10 Max: 14.3
Current: 14.82
-10.6
14.3
Shiller P/E 2.37
DHRM's Shiller P/E is ranked higher than
98% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 32.28 vs. DHRM: 2.37 )
Ranked among companies with meaningful Shiller P/E only.
DHRM' s 10-Year Shiller P/E Range
Min: 2.11  Med: 3.99 Max: 5.17
Current: 2.37
2.11
5.17
Current Ratio 8.45
DHRM's Current Ratio is ranked higher than
90% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. DHRM: 8.45 )
Ranked among companies with meaningful Current Ratio only.
DHRM' s 10-Year Current Ratio Range
Min: 1.96  Med: 6.80 Max: 9.57
Current: 8.45
1.96
9.57
Quick Ratio 6.77
DHRM's Quick Ratio is ranked higher than
88% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. DHRM: 6.77 )
Ranked among companies with meaningful Quick Ratio only.
DHRM' s 10-Year Quick Ratio Range
Min: 1.66  Med: 5.61 Max: 8.28
Current: 6.77
1.66
8.28
Days Inventory 246.86
DHRM's Days Inventory is ranked lower than
76% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 129.48 vs. DHRM: 246.86 )
Ranked among companies with meaningful Days Inventory only.
DHRM' s 10-Year Days Inventory Range
Min: 94.79  Med: 149.45 Max: 230.58
Current: 246.86
94.79
230.58
Days Sales Outstanding 360.10
DHRM's Days Sales Outstanding is ranked lower than
98% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.92 vs. DHRM: 360.10 )
Ranked among companies with meaningful Days Sales Outstanding only.
DHRM' s 10-Year Days Sales Outstanding Range
Min: 169.71  Med: 206.12 Max: 360.1
Current: 360.1
169.71
360.1

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 0.38
DHRM's Price/Net Current Asset Value is ranked higher than
99% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 6.33 vs. DHRM: 0.38 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
DHRM' s 10-Year Price/Net Current Asset Value Range
Min: 0.25  Med: 0.60 Max: 1.27
Current: 0.38
0.25
1.27
Price/Tangible Book 0.27
DHRM's Price/Tangible Book is ranked higher than
99% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 4.01 vs. DHRM: 0.27 )
Ranked among companies with meaningful Price/Tangible Book only.
DHRM' s 10-Year Price/Tangible Book Range
Min: 0.22  Med: 0.45 Max: 1.09
Current: 0.27
0.22
1.09
Price/Projected FCF 1.90
DHRM's Price/Projected FCF is ranked higher than
58% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. DHRM: 1.90 )
Ranked among companies with meaningful Price/Projected FCF only.
DHRM' s 10-Year Price/Projected FCF Range
Min: 1.54  Med: 2.34 Max: 3.14
Current: 1.9
1.54
3.14
Price/Median PS Value 1.17
DHRM's Price/Median PS Value is ranked lower than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. DHRM: 1.17 )
Ranked among companies with meaningful Price/Median PS Value only.
DHRM' s 10-Year Price/Median PS Value Range
Min: 0.46  Med: 1.68 Max: 1.99
Current: 1.17
0.46
1.99
Price/Graham Number 0.42
DHRM's Price/Graham Number is ranked higher than
99% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. DHRM: 0.42 )
Ranked among companies with meaningful Price/Graham Number only.
DHRM' s 10-Year Price/Graham Number Range
Min: 0.14  Med: 0.47 Max: 0.7
Current: 0.42
0.14
0.7
Earnings Yield (Greenblatt) (%) 6.71
DHRM's Earnings Yield (Greenblatt) (%) is ranked higher than
85% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. DHRM: 6.71 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DHRM' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.67  Med: 46.20 Max: 134.5
Current: 6.71
6.67
134.5
Forward Rate of Return (Yacktman) (%) -84.05
DHRM's Forward Rate of Return (Yacktman) (%) is ranked lower than
100% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 4.79 vs. DHRM: -84.05 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
DHRM' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -84.1  Med: -20.90 Max: -0.9
Current: -84.05
-84.1
-0.9

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:J8D.Germany,
Dehaier Medical Systems Ltd., was incorporated in the British Virgin Islands in 2003 as a limited liability company. The Company is in the business of developing and distributing medical devices. It distributes products designed and manufactured by other companies. The Company broadens its product portfolio through distribution agreements with international manufacturers, and the products it distributes are imported. Its distribution offerings are mostly equipment used in the operating room, the intensive care unit ('ICU') and the emergency room. Besides distributing medical devices, it also design, develop and market its own proprietary products and medical components. Because it does not run any manufacturing facilities, it contracts some of the medical components to outside manufacturers in China. Its proprietary products require light assembly by it before distribution. Its proprietary and distributed products include two major categories: medical devices (including supporting products); and sleep respiratory and oxygen therapy products (previously defined as respiratory and oxygen homecare products). Its medical devices proprietary and distributed products are mainly used in hospitals and clinics, while the sleep respiratory and oxygen therapy products are mainly for hospitals, sleep centers, at-home use by individual, emergency center, national defense and national disaster relief circumstances. It sells its products primarily through distributors, but it also makes direct sales to hospitals, clinics, government health bureaus, government organizations and individuals. It continue to further its market reach by introducing newer and more advanced product lines that address different end-user needs. Its competitors include publicly traded and privately held multinational companies, such as Respironics, Inc., ResMed Inc., and Covidien, as well as domestic Chinese companies such as Beijing Aoji, Beijing Ya'ao, Jiangsu Yuyue and Zhejiang Longfei. Its products are medical devices and are subject to regulatory controls governing medical devices. As a distributor of medical equipment and supplies it is subject to regulation and oversight by different levels of the food and drug administration in China, in particular the SFDA. It is also subject to other PRC government laws and regulations.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK